Literature DB >> 21972017

The transcription factor PU.1 is a critical regulator of cellular communication in the immune system.

Shereen A Turkistany1, Rodney P DeKoter.   

Abstract

PU.1 is an E26 transformation-specific family transcription factor that is required for development of the immune system. PU.1 functions at both early and late stages of lymphoid and myeloid differentiation. At least 110 direct target genes of PU.1 have been identified since its discovery in 1988. We used the published literature to determine if aspects of PU.1 function can be inferred from the identity of target genes that are directly activated. This analysis revealed that 61% of described PU.1 target genes encode extracellular proteins or transmembrane proteins, most of which are involved in cellular communication. The genes activated by PU.1 can be grouped into pathways based on function. Specific examples of cellular communication pathways regulated by PU.1 include (1) antibodies and antibody receptors, (2) cytokines and cytokine receptors regulating leukocyte growth and development, and (3) cytokines and cytokine receptors regulating inflammation. As a consequence of mutation or repression of the gene encoding PU.1, hematopoietic progenitors may be generated but there is a "failure to thrive" because they cannot interact with their environment. The loss of cellular communication caused by reduced PU.1 levels can lead to leukemia. In summary, PU.1 is a critical regulator of cellular communication in the immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972017     DOI: 10.1007/s00005-011-0147-9

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  37 in total

1.  Nrf2 regulates PU.1 expression and activity in the alveolar macrophage.

Authors:  Bashar S Staitieh; Xian Fan; Wendy Neveu; David M Guidot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-03       Impact factor: 5.464

2.  Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.

Authors:  Marissa Morales Del Real; Ellen V Rothenberg
Journal:  Development       Date:  2013-03       Impact factor: 6.868

3.  The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation.

Authors:  Feng Qian; Jing Deng; Yong Gyu Lee; Jimmy Zhu; Manjula Karpurapu; Sangwoon Chung; Jun-Nian Zheng; Lei Xiao; Gye Young Park; John W Christman
Journal:  J Mol Cell Biol       Date:  2015-06-22       Impact factor: 6.216

4.  Nfkb1 activation by the E26 transformation-specific transcription factors PU.1 and Spi-B promotes Toll-like receptor-mediated splenic B cell proliferation.

Authors:  Stephen K H Li; Ali K Abbas; Lauren A Solomon; Gaëlle M N Groux; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

5.  Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.

Authors:  Lauren A Solomon; Shreya Podder; Jessica He; Nicholas L Jackson-Chornenki; Kristen Gibson; Rachel G Ziliotto; Jess Rhee; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

6.  A combined computational and experimental approach reveals the structure of a C/EBPβ-Spi1 interaction required for IL1B gene transcription.

Authors:  Sree H Pulugulla; Riley Workman; Nathan W Rutter; Zhiyong Yang; Juraj Adamik; Brian Lupish; David A Macar; Samir El Abdouni; Emilio Xavier Esposito; Deborah L Galson; Carlos J Camacho; Jeffry D Madura; Philip E Auron
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

7.  Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.

Authors:  Krishnakumar Malu; Rahul Garhwal; Margery G H Pelletier; Deepali Gotur; Stephanie Halene; Monika Zwerger; Zhong-Fa Yang; Alan G Rosmarin; Peter Gaines
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

Review 8.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 9.  Playing TETris with DNA modifications.

Authors:  Benjamin Delatte; Rachel Deplus; François Fuks
Journal:  EMBO J       Date:  2014-05-13       Impact factor: 11.598

10.  High expression of PU.1 is associated with Her-2 and shorter survival in patients with breast cancer.

Authors:  Jing Lin; Wei Liu; Tian Luan; Lili Yuan; Wei Jiang; Huilong Cai; Weiguang Yuan; Yuwen Wang; Qingyuan Zhang; Lihong Wang
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.